Newsroom > In the News
In the news
News headlines are articles that reference ResMed's company, people, or business practices.
April 10, 2017FeibusTech
Mike Feibus tries S+, the world's first non-contact sleep tracker, discusses what it does, what it has, and more.
April 4, 2017American Thoracic Society
The American Thoracic Society today announced a new $100,000 two-year research fellowship funded by ResMed in the area of noninvasive ventilation (NIV) in chronic obstructive pulmonary disease (COPD).
March 23, 2017Mergers & Acquisitions
“Brightree was an important and immediately accretive strategic acquisition for ResMed. It exemplified a double-down on our ongoing investments to leverage connected care and digital health, and to change the basis of competition in our industry,” ResMed CEO Mick Farrell told Mergers & Acquisitions in a March 2017 interview. “One year from announcing the acquisition, we can reaffirm our goals going in: Brightree represents a big step forward for ResMed, fulfilling our role as the world’s leading tech-driven medical device company, liberating data and unlocking incredible value for our customers.”
March 21, 2017Crain's San Diego
The toughest moments are the ones that contribute most to developing strength and leadership. That point came for me in Lyon, France, early in my tenure as CEO. I had been on a round-the-world business trip that spanned seven countries in 14 days. It was Sunday morning, and I had gone for a run and had just had a lovely lunch, but when I returned to my hotel room, I suddenly felt deathly lonely.
March 3, 2017Dossier, Hemispheres by United Airlines (see page 8)
“If [ResMed] still can be known as the world leader in respiratory medicine, that’s great, but if we can be known as the world’s leading tech-driven medical device company, that liberated data and inspired people in other disease states beyond sleep apnea and COPD to do so, we’ll really get there,” says CEO Mick Farrell.